A detailed history of Integrated Wealth Concepts LLC transactions in Argenx Se stock. As of the latest transaction made, Integrated Wealth Concepts LLC holds 568 shares of ARGX stock, worth $356,885. This represents 0.0% of its overall portfolio holdings.

Number of Shares
568
Previous 594 4.38%
Holding current value
$356,885
Previous $255,000 20.78%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$434.22 - $551.9 $11,289 - $14,349
-26 Reduced 4.38%
568 $308,000
Q2 2024

Aug 14, 2024

BUY
$356.01 - $451.55 $712 - $903
2 Added 0.34%
594 $255,000
Q4 2023

Feb 13, 2024

BUY
$338.91 - $506.01 $338 - $506
1 Added 0.17%
592 $225,000
Q3 2023

Nov 15, 2023

SELL
$369.35 - $548.43 $41,736 - $61,972
-113 Reduced 16.05%
591 $290,000
Q2 2023

Aug 15, 2023

BUY
$360.14 - $422.58 $253,538 - $297,496
704 New
704 $274,000

Others Institutions Holding ARGX

About ARGENX SE


  • Ticker ARGX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,323,800
  • Market Cap $34.8B
  • Description
  • argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...
More about ARGX
Track This Portfolio

Track Integrated Wealth Concepts LLC Portfolio

Follow Integrated Wealth Concepts LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Integrated Wealth Concepts LLC, based on Form 13F filings with the SEC.

News

Stay updated on Integrated Wealth Concepts LLC with notifications on news.